JAVIER
PUENTE VÁZQUEZ

Profesor asociado

Foto de JAVIER

Foto de Clínica Universitaria de Navarra

Clínica Universitaria de Navarra

Pamplona, España

Publicaciones en colaboración con investigadores/as de Clínica Universitaria de Navarra (4)

2024

Induction avelumab followed by chemoimmunotherapy and maintenance versus chemotherapy alone as first-line therapy in cis-ineligible metastatic urothelial carcinoma (INDUCOMAIN): a randomized phase II study
ESMO Open, Vol. 9, Núm. 9

2021

Atezolizumab in locally advanced or metastatic urothelial cancer: a pooled analysis from the Spanish patients of the IMvigor 210 cohort 2 and 211 studies
Clinical and Translational Oncology, Vol. 23, Núm. 4, pp. 882-891
Circulating levels of the interferon-γ-regulated chemokines cxcl10/cxcl11, il-6 and hgf predict outcome in metastatic renal cell carcinoma patients treated with antiangiogenic therapy
Cancers, Vol. 13, Núm. 11

2014

Identification of tissue microRNAs predictive of sunitinib activity in patients with metastatic renal cell carcinoma
PLoS ONE, Vol. 9, Núm. 1